Published Nov 2026
Citation
Desai A, Dong OM, Gautier SCZ, et al. Systematic review of health economic evaluations of oral nutritional supplement interventions in older adults: an ISPOR Special Interest Group report. Value Health. 2026; (29)11:1933-1951.
Abstract
Objectives
This systematic literature review synthesizes findings from health economic evaluations in older adults receiving oral nutrition supplement (ONS) interventions.
Methods
Six databases (PubMed, Embase, EconLit, CINAHL, Cochrane, and Scopus) were searched for health economic evaluations published from 2014 to 2024 comparing ONS with any comparator in populations with mean age ≥60 years. The Consolidated Health Economic Evaluation Reporting Standards checklist informed data extraction and reporting quality. Methodological quality was assessed using the Drummond checklist. This study was registered with PROSPERO (CRD42023459161).
Results
Of the 1459 records identified, 12 studies met the inclusion criteria: 4 cost-effectiveness analyses (CEA), 2 cost-utility analyses, 3 budget-impact analyses, 1 cost-minimization analysis, 1 CEA plus cost-utility analyses, and 1 budget-impact analyses plus CEA. Most studies were conducted in hospital (n = 4) or community settings (n = 4) with time horizons ≤ 6 months (n = 10). Most were trial based (n = 8), used usual care comparators (n = 8), and included both healthcare and intervention costs (n = 11). Seven studies reported ONS intervention-arm cost savings up to US$1988/patient, primarily from reduced healthcare resource utilization, whereas 5 studies reported cost increases (as low as 2024 US$356/patient), mainly from intervention-related costs. Main health outcomes and utilization were favorable in 9 studies, whereas 3 studies reported mixed findings across several main outcomes. Studies concluded ONS interventions were cost-effective or cost saving; however, comparability was limited by heterogeneity in methods, settings, and outcomes.
Conclusions
ONS interventions were generally associated with short-term improvements in patient outcomes with minimal incremental costs, but evaluations with longer time horizons are needed to characterize longer-term impacts.Full Content
Log In to View ReportQuestions?
For any questions about this report please contact us.